Osteosarcoma with cell-cycle and fibroblast growth factor genomic alterations: case report of Molecular Tumor Board combination strategy resulting in long-term exceptional response

We report a 31-year-old woman with chemotherapy –refractory metastatic osteosarcoma who was successfully treated with the com...
Source: Journal of Hematology and Oncology - Category: Hematology Authors: Tags: Correspondence Source Type: research